Home
Reels
Grupos
Páginas
Más
Grupos Páginas Eventos Blogs Financiamiento
Iniciar sesión Registrarse
Night Mode
Triple-Negative Breast Cancer: The Frontline of Innovation in HER2 Negative Disease
Within the HER2 negative breast cancer category, triple-negative breast cancer (TNBC) stands out as the most aggressive and historically most challenging subtype. Lacking estrogen receptors, progesterone receptors, and HER2 expression, TNBC doesn't respond to targeted therapies that benefit other breast cancer types, leaving chemotherapy as the mainstay for decades. That's changing...
0 Commentarios ·0 Acciones ·13 Views ·0 Vista previa
Please log in to like, share and comment!